In contrast, no differences were observed for anti-gp140 IgA titers, globally lower than for IgGs, between early- and late-treated animals after ATI, which may be related to a lower frequency of IgA-memory B cells triggered upon primary infection or with a shorter half-life compared to IgG-memory cells. The gene discussed is CD79A; the disease is infection.